MedPath

Development of Evidence-based Therapeutic Guidelines for Early SLA in Urdu-speaking Children With Cochlear Implants

Active, not recruiting
Conditions
Cochlear Hearing Loss
Registration Number
NCT07068373
Lead Sponsor
Superior University
Brief Summary

Firstly global and regional literature on speech therapy after cochlear implantation focusing on Urdu-speaking populations and culturally relevant factors will be systematically reviewed.

Detailed Description

Then needs Assessment will be done to understand the challenges, needs, and gaps in therapeutic practices specific to Urdu-speaking children through focus groups to gather insights into current practices and barriers. After that objective data will be collected to identify trends and outcomes in speech and language development post-implantation, measure baseline skills, and progress over time, and factors influencing outcomes i.e. age of implantation, therapy frequency. In final stage, culturally relevant and evidence-based therapeutic guidelines will be formulated.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Speech language Pathologists/ therapist with minimum 5 years of experience working with cochlear implant
  • Parents of children with cochlear implant age 2 and above
Exclusion Criteria
  • Parents whose children has just cochlear implant and they have no experience of speech and language development after cochlear implant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Likert scale18 Months

A Likert scale is a psychometric scale commonly used in questionnaires to measure respondents' attitudes and opinions. It typically presents a statement and asks respondents to indicate their level of agreement or disagreement using a range of ordered response options. These options are usually assigned numerical values for scoring purposes. Scoring is designed based on such categories as "Strongly Disagree," "Disagree," "Neither Agree nor Disagree," "Agree," and "Strongly Agree." (0-5) for each question, the higher the score indicates the worse condition

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Lahore City

🇵🇰

Lahore, Pakistan

Lahore City
🇵🇰Lahore, Pakistan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.